SLC1A5 and brain neoplasm: However, it has not been established whether fluciclovine PET uptake provides reliable quantification of brain tumor LAT1 and ASCT2 levels or whether fluciclovine PET measurements might be confounded by other physiologic processes, such as enhanced delivery due to blood-brain barrier breakdown (16).